Paraoxonase 1 Gene Polymorphisms Do Not Influence the Response to Treatment in Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|32|1|26-31

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.32, Iss.1, 2011-08, pp. : 26-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paraoxonase Gene Polymorphism and the Risk for Alzheimer’s Disease in the Polish Population

By  

Dementia and Geriatric Cognitive Disorders, Vol. 31, Iss. 6, 2011-07 ,pp. : 417-423

Karger

Access to resources Recommend Favorite

Treatment of Delusions in Alzheimer’s Disease – Response to Pharmacotherapy

By  

Dementia and Geriatric Cognitive Disorders, Vol. 22, Iss. 3, 2006-08 ,pp. : 260-266

Karger

Access to resources Recommend Favorite

Interleukin 1 Alpha Gene Polymorphism as a Susceptibility Factor in Alzheimer’s Disease and Its Influence on the Extent of Histopathological Hallmark Lesions of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 3, 2002-09 ,pp. : 123-127

Karger

Access to resources Recommend Favorite

Progression from Amnesic Mild Cognitive Impairment to Alzheimer’s Disease: ESR1 and ESR2 Polymorphisms and APOE Gene

By  

Dementia and Geriatric Cognitive Disorders, Vol. 32, Iss. 5, 2012-02 ,pp. : 332-341

Karger

Access to resources Recommend Favorite

The Regulatory Region Polymorphisms of the MTHFR Gene Are Not Associated with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 17, Iss. 3, 2004-03 ,pp. : 147-150

Karger

Access to resources Recommend Favorite